Early evidence suggests US Food and Drug Administration Commissioner nominee Martin Makary could be a more “conventional” agency leader than others in President Trump’s second administration.
US FDA Under Makary: MAHA With A Lighter Touch
US FDA Commissioner nominee Martin Makary is being embraced by industry, and Senate Democrats, as a more traditional pick than other Trump Administration nominees, but the Make America Healthy Again agenda still is clearly coming to the agency.
